Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
BVAXF
Primary Symbol:
C.BIOV
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
NewMexicats
X
View Profile
View Bullboard History
Comment by
NewMexicats
on Nov 14, 2024 1:28pm
RE:RE:Article in Nature about DPX Anthrax
Just related to CEO Passin mentioning in recent interviews that DPX Anthrax has potential DOD avenue because data is better for DPX, and Ciprofloxin not required like current Anthrax vax. Then
...more
(18)
•••
javaman12
X
View Profile
View Bullboard History
Post by
javaman12
on Nov 13, 2024 6:13pm
Big Volume Day!!
Let's hope that this trend continues! It's good for the future share price and good for the company! If large volume trades like this continue, I would like to think that some very savy
...more
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 13, 2024 2:39pm
1.7 million shares traded 3 million in 3 days-consolidation
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr C ATS 50.1 0.065 · 0.07 63.0
...more
(84)
•••
WinterBaron
X
View Profile
View Bullboard History
Comment by
WinterBaron
on Nov 13, 2024 1:30pm
RE:Article in Nature about DPX Anthrax
This appears to be an article/study released in February 2019 . Is there current material related to it that brings new focus to IMV component?
(4)
•••
venturetown
X
View Profile
View Bullboard History
Post by
venturetown
on Nov 13, 2024 11:13am
Article in Nature about DPX Anthrax
https://www.nature.com/articles/s41541-019-0102-z
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 13, 2024 11:02am
Over 1 million shares traded first 90 minutes all markets
Bid - Ask Last Chg %Ch Vol $Vol #Tr 49.5 0.065 · 0.07 27.0 0.065 &
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 13, 2024 10:20am
Level 2 bid ask update Over 600k traded. Weak asks to .085
Ask 0.085 4,000 2 0.08 16,000 1 0.075 30,000 1 0.07 27,000 2 0.065
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 13, 2024 10:12am
Current level 2 bid ask
Ask 0.08 16,000 1 0.075 30,000 1 0.07 27,000 2 0.065 59,000 4 0.06
...more
(84)
•••
WinterBaron
X
View Profile
View Bullboard History
Comment by
WinterBaron
on Nov 13, 2024 10:08am
RE:RE:Why is there little market confidence in Biovaxys?
Very thoughtful and comprehensive summary javaman12. Certainly the kind of comment that many bullboards would respect and could use.
(5)
•••
NewMexicats
X
View Profile
View Bullboard History
Comment by
NewMexicats
on Nov 13, 2024 2:57am
RE:RE:Why is there little market confidence in Biovaxys?
IMO in order to see real movement in Biovaxys, they need to generate cash thru something other than a private placement. As the last extended private placement halted early, this appears to be
...more
(18)
•••
javaman12
X
View Profile
View Bullboard History
Comment by
javaman12
on Nov 12, 2024 11:06pm
RE:Why is there little market confidence in Biovaxys?
What's so extraordinary? Have you looked around at the junior resource sector lately? These kind of price swings are normal. However, in the junior or senior precious metals and copper space, the
...more
(84)
•••
WinterBaron
X
View Profile
View Bullboard History
Post by
WinterBaron
on Nov 12, 2024 4:20pm
Why is there little market confidence in Biovaxys?
Does this extraordinarily erradic trading volume and share price instability exist due to lack of confidence or trust in management? Definitely the Cease Trade Order in May pointed to weak
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Nov 12, 2024 3:36pm
FYI: Regarding high volume trading platforms
FYI ATS (Alternative Trading System) was used by anonymous trading today so far for over a million shares has been the main trader. Summary Alternative Trading Systems (ATS) are a
...more
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Comment by
Hideaway
on Nov 12, 2024 2:29pm
RE:Lipid Delivery Licences Can Be Valuable!
Javaman,I agree with you.DPX has tremendous potential and management is doing great PR work promoting the benefits.No comparison to the lacklustre effort of IMV. Merck financed the start of the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario